Publishing research using ab25062? Please let us know so that we can cite the reference in this datasheet.

ab25062 has been referenced in 1 publication.

  • Phillips DC  et al. Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199). Blood Cancer J 5:e368 (2015). PubMed: 26565405

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up